S'abonner

Impaired intestinal tolerance in the absence of a functional complement system - 30/03/13

Doi : 10.1016/j.jaci.2012.09.004 
Pirkka T. Pekkarinen, MD a, , Kirsi Vaali, PhD a, b, c, Hanna Jarva, MD, PhD a, d, Eliisa Kekäläinen, MD, PhD a, Iivo Hetemäki, MB a, Sami Junnikkala, PhD a, e, Merja Helminen, MD, PhD f, Outi Vaarala, MD, PhD b, Seppo Meri, MD, PhD a, d, T. Petteri Arstila, MD, PhD a
a Department of Bacteriology and Immunology, Haartman Institute, University of Helsinki, Helsinki, Finland 
e Department of Basic Veterinary Sciences, Faculty of Veterinary Medicine, University of Helsinki, Helsinki, Finland 
b Department of Vaccination and Immune Protection, Immune Response Unit, National Institute for Health and Welfare, Helsinki, Finland 
c Institute of Medicine, University of Bergen, Bergen, Norway 
d HUSLAB and Helsinki University Central Hospital, Helsinki, Finland 
f Paediatric Research Centre, Tampere University and University Hospital, Tampere, Finland 

Corresponding author: Pirkka T. Pekkarinen, MD, Haartman Institute, Department of Bacteriology and Immunology, PB 21, 00014 University of Helsinki, Finland.

Abstract

Background

Cells of the innate immune system regulate both adaptive immune responses and the maintenance of tolerance, especially in the gut. However, relatively little is known about the effects of complement on lymphocyte homeostasis.

Objective

This study explored complement C3 deficiency in mice and human subjects for its effect on intestinal tolerance.

Methods

C3-deficient mice and control C57BL/6 mice were fed ovalbumin (OVA) by means of gavage, and subsequent response to immunization with OVA in Freund's adjuvant was monitored. Serum antibodies against commensal microbes were measured, and the activation status of peripheral blood lymphocytes bearing mucosal homing markers was determined from 2 rare cases of C3-deficient patients.

Results

We show in C3-deficient mice and human patients that intestinal tolerance fails in the absence of functional complement. In contrast to wild-type control animals, in which oral tolerance was induced, intragastric administration of OVA did not result in a significantly decreased response to subsequent subcutaneous OVA challenge in C3-deficient mice. In the jejunum of C3-deficient mice the cytokine ratio between IL-10 and IFN-γ or IL-17 levels was decreased, indicating a shift in favor of proinflammatory cytokines. In 2 C3-deficient children the frequency of gut-homing T cells expressing activation markers was increased, and the patients had increased serum IgG levels against gut commensal microbes. The data also suggest that the impaired oral tolerance was at least partly caused by the absence of signaling through C3-binding complement regulators in T cells.

Conclusions

Taken together, our results identify complement as an important and nonredundant regulator of intestinal tolerance.

Le texte complet de cet article est disponible en PDF.

Key words : Mucosal immunity, peripheral tolerance, complement C3, T lymphocytes, humoral immunity

Abbreviations used : C3ctrl, C3OVA, FOXP3, HRP, KO, OVA, PE, TCR, WT, WTctrl, WTOVA


Plan


 Supported by the Academy of Finland, Sigrid Jusélius Foundation, Finnish Cultural Foundation, Finnish Medical Foundation, Helsinki Biomedical Graduate School, Helsinki University Central Hospital funds (EVO), and HUSLAB funds.
 Disclosure of potential conflict of interest: P. T. Pekkarinen has received research support from the Finnish Cultural Foundation. O. Vaarala is on the Board of the Hero Institute for Infant Nutrition. S. Meri is employed by the University and University Hospital of Helsinki, has received research support from the Sigrid Jusélius Foundation and the Helsinki University Hospital Funds, has received lecture fees from Alexion, has received payment for developing educational presentations from the Academy for Complement Inhibition, and has received travel expenses from the International Congress. T. P. Arstila has received lecture fees from Schering-Plough, Bristol-Myers Squibb, and Roche. The rest of the authors declare that they have no relevant conflicts of interest.


© 2012  American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 131 - N° 4

P. 1167-1175 - avril 2013 Retour au numéro
Article précédent Article précédent
  • The proteome of Toll-like receptor 3–stimulated human immortalized fibroblasts: Implications for susceptibility to herpes simplex virus encephalitis
  • Rebeca Pérez de Diego, Claire Mulvey, Mark Crawford, Matthew W.B. Trotter, Lazaro Lorenzo, Vanessa Sancho-Shimizu, Laurent Abel, Shen-Ying Zhang, Jean-Laurent Casanova, Jasminka Godovac-Zimmermann
| Article suivant Article suivant
  • A meta-analysis of genome-wide association studies for serum total IgE in diverse study populations
  • Albert M. Levin, Rasika A. Mathias, Lili Huang, Lindsey A. Roth, Denise Daley, Rachel A. Myers, Blanca E. Himes, Isabelle Romieu, Mao Yang, Celeste Eng, Julie E. Park, Karla Zoratti, Christopher R. Gignoux, Dara G. Torgerson, Joshua M. Galanter, Scott Huntsman, Elizabeth A. Nguyen, Allan B. Becker, Moira Chan-Yeung, Anita L. Kozyrskyj, Pui-Yan Kwok, Frank D. Gilliland, W. James Gauderman, Eugene R. Bleecker, Benjamin A. Raby, Deborah A. Meyers, Stephanie J. London, Fernando D. Martinez, Scott T. Weiss, Esteban G. Burchard, Dan L. Nicolae, Carole Ober, Kathleen C. Barnes, L. Keoki Williams

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.